XML 90 R74.htm IDEA: XBRL DOCUMENT v3.21.1
Capital Stock - Additional Information (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2021
USD ($)
shares
Mar. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2020
$ / shares
Dec. 31, 2020
USD ($)
shares
Jun. 30, 2020
USD ($)
Jun. 11, 2020
shares
Jul. 01, 2017
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share-based compensation costs recorded for the period | $ $ 5,300,000     $ 4,200,000      
Stock-based compensation expense | $ $ 5,307,000 $ 4,192,000          
Maximum number of shares of common stock may be issued for outstanding PSU 59,358,679     58,921,731      
Common shares purchased in open market by trustee in connection with RSUs   200,000          
Weighted average price of common shares purchased in open market by trustee in connection with RSUs | $ / shares   $ 15.43          
Number of treasury shares held in trust for future settlement of share based awards 723     723      
Value of treasury shares held in trust for future settlement of RSUs and stock options | $ $ 11,000     $ 11,000      
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units 6,494,829 6,995,927          
IMAX China              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Details of the share repurchase program In 2020, IMAX China announced that its shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 11, 2020 (34,848,398 shares). This program will be valid until the 2021 Annual General Meeting of IMAX China, which is scheduled for May 6, 2021. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.            
Repurchase of common shares   480,600          
Stock Acquired, Average Cost per Share | (per share)   $ 1.85 $ 14.42        
Stock Repurchase Program, maximum percentage of shares to be repurchased           10.00%  
Stock Repurchase Program, Authorized number of shares           34,848,398  
Stock repurchase program expiration year 2021            
Parent [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Details of the share repurchase program In June 2020, the Company’s Board of Directors approved a 12-month extension to its share repurchase program, through June 30, 2021. The extension authorized the Company to repurchase up to approximately $89.4 million worth of common shares, the remaining amount available of the original $200.0 million initially authorized under the share-repurchase program when it commenced on July 1, 2017. Subsequent to March 31, 2021, the Company’s Board of Directors approved a further 12-month extension of the current share repurchase program through June 30, 2022. The repurchases may be made either in the open market or through private transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.            
Stock Repurchase Program, Authorized Amount | $             $ 200,000,000.0
Stock Repurchase Program Expiration Date Jun. 30, 2021            
Repurchase of common shares 0 2,484,123          
Stock Acquired, Average Cost per Share | $ / shares   $ 14.72          
Maximum [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Value of treasury shares held in trust for future settlement of RSUs and stock options | $ $ 100,000     $ 100,000      
Maximum [Member] | Parent [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock Repurchase Program, Authorized Amount | $         $ 89,400,000    
Restricted Share Units [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense | $ $ 3,151,000 $ 2,902,000          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units 1,735,714 1,692,066          
Restricted Share Units [Member] | Minimum [Member] | Certain Advisor [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense | $   $ 100,000          
Employee Stock Option [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense | $ $ 351,000 $ 513,000          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units 3,913,231 4,944,077          
Performance Stock Units [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense | $ $ 1,014,000 $ 279,000          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units 845,884 359,784          
Performance Stock Units [Member] | Maximum [Member] | EBITDA              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Maximum number of shares of common stock may be issued for outstanding PSU 1,168,573